XML 35 R23.htm IDEA: XBRL DOCUMENT
v3.20.4

16. Warrants | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2020 | Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract] |  |
Warrants | NOTE 14 – WARRANTS Warrants are immediately exercisable upon issuance. The following table shows warrant activity for the nine months ended September 30, 2020.
|  | Number of shares |  |  | Weighted Average Exercise Price |
Warrants outstanding as of December 31, 2019 |  |  | 692,034 |  |  | $ | 2.88 |
Issued in conjunction with debt |  |  | 124,481 |  |  | $ | 2.41 |
Issued in conjunction with agreement with former executive (see Note 13 – Shareholders’ Equity) |  |  | 400,000 |  |  | $ | 1.00 |
Warrants outstanding as of September 30, 2020 |  |  | 1,216,515 |  |  | $ | 2.21 |
Warrants exercisable as of September 30, 2020 |  |  | 1,216,515 |  |  | $ | 2.21 |
The weighted-average life of the warrants is 2.5 years. The aggregate intrinsic value of the warrants outstanding and exercisable at September 30, 2020 is $0. | NOTE 16 – WARRANTS The following table shows warrant activity for the years ended December 31, 2019 and 2018.
|  | December 31,
|  | 2019
|  | Number of shares |  | Weighted Average Exercise Price
Warrants outstanding as of December 31, 2018 |  |  | 6,000 |  |  | $ | 1.00 |
Warrants issued in connection with convertible debenture offering (see Note 10): |  |  |  |  |  |  |  |
Issued to convertible debenture holders |  |  | 532,134 |  |  | $ | 3.00 |
Issued to 4Front as part of compensation |  |  | 153,900 |  |  | $ | 2.41 |
Warrants outstanding as of December 31, 2019 |  |  | 692,034 |  |  | $ | 2.88 |
Warrants exercisable as of December 31, 2019 |  |  | 692,034 |  |  | $ | 2.88 |
The warrants issued to convertible debenture holders expire June 24, 2021. The warrants issued to 4Front as part of compensation expire May 31, 2021. Warrants issued to Mr. Lowe in 2018 expire March 31, 2023. The aggregate intrinsic value of the warrants outstanding and exercisable at December 31, 2019 is $0.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration